Advertisement
U.S. Markets close in 6 hrs 13 mins

Structure Therapeutics Inc. (GPCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
37.99-0.36 (-0.94%)
As of 09:45AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close38.35
Open38.54
Bid37.49 x 100
Ask38.56 x 200
Day's Range37.62 - 38.58
52 Week Range26.61 - 66.38
Volume21,716
Avg. Volume676,721
Market Cap2.173B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.19
Earnings DateAug 08, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est87.90
  • GlobeNewswire

    Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

    SAN FRANCISCO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced multiple upcoming posters at The Obesity Society's Annual Meeting, ObesityWeek®, taking place from November 3-6, 2024 in San Antonio, TX. Title: Novel Oral Small Molecule Dual Amylin and Calcitonin Receptor Agonists for Obesity TreatmentPoster Number: P

  • BioPharma Dive

    GPCR drugmaker Septerna amasses $288M in IPO

    Septerna upped the size of its offering twice before pricing a stock sale that raised funds for its lead candidate, a treatment for hypoparathyroidism now in Phase 1 testing.